NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1095 coverSignal Transduction Pathways, Part C: Cell Signaling in Health and Disease Volume 1095 published December 2006
Ann. N.Y. Acad. Sci. 1095: 193–203 (2007). doi: 10.1196/annals.1397.023
Copyright © 2007 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via Google Scholar
Google Scholar
Articles by BRAGADIN, M.
Articles by BORDIN, L.
Search for Related Content
PubMed
PubMed Citation
Articles by BRAGADIN, M.
Articles by BORDIN, L.

Part II. Cell Signaling in Health and Disease

SHP-1 Tyrosine Phosphatase in Human Erythrocytes

MARCANTONIO BRAGADINa, FLORINA ION-POPAb, GIULIO CLARIb AND LUCIANA BORDINb

a Dipartimento di Scienze Ambientali, Università di Venezia, 30123 Venezia, Italy b Dipartimento di Chimica Biologica, Università di Padova, 35121 Padova, Italy

Key Words: SHP-1 • tyrosine-phosphorylation • band 3 • human erythrocyte

Address for correspondence: Marcantonio Bragadin, Dipartimento di Scienze Ambientali, Dorsoduro 2137, University of Padova, 30123 Venezia, Italy. Voice: +39-041-2348507; fax: +39-041-2348605.  e-mail: bragadin{at}unive.it

SHP-1 is a SH2-domain containing protein Tyr-phosphatase expressed in hematopoietic cell lines, which is hypothesized to play a negative role in signal transduction. In human erythrocytes, the phospho-Tyr level of proteins, mainly transmembrane band 3, is closely controlled by the antithetic activity of Tyr-protein kinases and phosphatases, resulting in a dephosphorylated state. Only after particular stimuli, as with oxidizing agents, diamide or pervanadate, or thiol alkylating compound, N-ethyl maleimide (NEM), Tyr-phosphorylation of band 3 can be triggered, inhibiting Tyr-phosphatase action and inducing erythrocyte membrane reorganization. We demonstrate that, in human erythrocytes, SHP-1 is present in membranes from resting cells, but in 5% of the protein amount. Interestingly, this amount increases up to threefold following NEM treatment of intact cells, whereas diamide and pervanadate do not alter the normal protein location. In addition, SHP-1 translocation from cytosol to membrane is not affected by band 3 P-Tyr level, because it is not mediated by the SH2-P-Tyr recruitment mechanism, and localizes into the cytoskeletal compartment. Band 3 is the target of SHP-1, which dephosphorylates Tyr 8, 21, and 904. These findings support the idea that, in human erythrocytes, the normal level of Tyr-phosphorylation of membrane protein, mainly band 3, must be downregulated. We hypothesize that the presence of both SHP-2 and SHP-1 ensures band 3 dephosphorylation in different conditions: SHP-2, through interaction of its SH2 domain/s to P-Tyr protein, is regulated by the band 3 Tyr-phosphorylation level; SHP-1 may be involved by simple membrane rearrangement.






footerLeft footerRight